Preparation and evaluation of gastroretentive floating tablets of acyclovir

Current Drug Delivery

Volumn 6, Issue 5, 2009, Pages 437-443

  Garg, Rajeev ^a   Gupta, G D ^a  

^a Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy   (India)

Author keywords

Crospovidone; Floating; Gastroretentive; Microcrystalline cellulose; Polypropylene foam powder

Indexed keywords

ACICLOVIR; BETA CYCLODEXTRIN; BICARBONATE; CELLULOSE; CITRIC ACID; CROSPOVIDONE;

ARTICLE; CONTROLLED STUDY; DRUG RELEASE; DRUG RETENTION; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; EFFERVESCENT TABLET; IN VITRO STUDY; PRIORITY JOURNAL; STOMACH; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TABLET POROSITY;

ACYCLOVIR; BETA-CYCLODEXTRINS; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; KINETICS; METHYLCELLULOSE; PHARMACEUTIC AIDS; POVIDONE; TABLETS; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 72149126093     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109789941678     Document Type: Article

References (29)

1. 2 gas-forming agents. Int. J. Pharm., 2002, 239, 81-91.
2. Garg, R.; Gupta, G. D. Progress in controlled Gastroretentive delivery systems. Trop. J. Pharm. Res., 2008, 7, 1055-1066.
3. Streubel, A.; Siepmann, J.; Bodmeier, R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv., 2006, 3, 217-233.
4. Ali, J.; Arora, S.; Khar, R. K. Floating Drug Delivery Systems: A Review. AAPS Pharm. Sci. Tech., 2005, 6, E372-E390.
5. Ponchel, G.; Irache J. M. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev., 1998, 34, 191-219. (Pubitemid 28535112)
6. Deshpande, A. A.; Shah, N. H.; Rhodes, C. T.; Malick, W. Development of a novel controlled-release system for gastric retention. Pharm. Res., 1997, 14, 815-819. (Pubitemid 27281680)
7. Davis, S. S.; Stockwell, A. F.; Taylor, M. J.; Hardy, D. R.; Whalley, C. G.; Wilson, H.; Bechgaard, F. N. Christensen: The effect of density on the gastric emptying of single- and multiple-unit dosage forms. Pharm. Res., 1986, 3, 208-213.
8. Klausner, E. A.; Lavy, E.; Friedman, M.; Hoffman A. Expandable gastroretentive dosage forms. J. Control Release, 2003, 90, 143-162.
9. Kedzierewicz, F.; Thouvenot, P.; Lemut, J.; Etienne, A.; Hoffman M.; Maincent, P. Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. J. Control Release, 1999, 58, 195-205.
10. Srivastava, A. K.; Wadhwa, S.; Ridhurkar, D.; Mishra, B. Oral Sustained Delivery of Atenolol from Floating Matrix Tablets - Formulation and In Vitro Evaluation. Drug Dev. Ind. Pharm., 2005, 31, 367-374. (Pubitemid 41289149)
11. Singh, B. N.; Kim, K. H. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Release, 2000, 63, 235-239.
12. Antona, J.W.; Diana, F.; Karen, L.G. Acyclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficiency. Drugs, 1994, 47, 153-205.
13. De Jalon, E.G.; Blanco-Prieto, N.J.; Ygartua, P.; Santoyo, S. Topical application of acycovir-loaded microparticles: quantification of the drug in porcine skin layers. J. Control. Release, 2001, 75, 191-197. (Pubitemid 32635209)
14. Conti, B.; Bucolo, C.; Giannavola, C.; Puglisi, G.; Giunchedi, P.; Conte, U. Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro/in vivo evaluation. Eur. J. Pharm. Sci., 1997, 5, 287-293. (Pubitemid 27397783)
15. Groning, R.; Berntgen, M.; Georgarakis, M. Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extacorporal magnets to control gastrointestinal transit. Eur. J. Pharm. Biopharm., 1998, 46, 285-291. (Pubitemid 29057675)
16. Junyaprasert, V. B.; Pornsuwannapha, S. Floating Properties and Release Characteristics of Hollow Microspheres of Acyclovir. Drug Deliv., 2008, 15, 331-341.
17. Baumgartner, S.; Kristl, J.; Vrecez, F.; Vodopivee, P.; Zorko B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm., 2000, 195, 125-135. (Pubitemid 30089497)
18. Gerogiannis, V. S.; Rekkas, D. M.; Dallas, P. P.; Choulis, N. H. Floating and swelling characteristics of various excipients used in controlled release technology. Drug Dev. Ind. Pharm., 1993, 19, 1061-1081.
19. Jaimini, M.; Rana, A. C.; Tanwar, Y. S. Formulation and evaluation of famotidine floating tablets. Curr. Drug Deliv., 2007, 4, 51-55. (Pubitemid 46066414)
20. Chavanpatil, M.; Jain, P.; Chaudhari, S.; Shear, R.; Vavia, P. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. Int. J. Pharm., 2005, 304, 178-184. (Pubitemid 41427660)
21. Rahman, Z.; Ali, M.; Khar, R. K. Design and evaluation of bilayer floating tablets of captopril. Acta Pharm., 2006, 56, 49-57. (Pubitemid 43253972)
22. Chavanpatil, M.; Jain, P.; Chaudhari, S.; Shear, R.; Vavia, P. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin Int. J. Pharm., 2006, 316, 86-92. (Pubitemid 43765689)
23. Sung, K.C.; Nixon, P.R.; Skoug, J.W.; Ju, T.R.; Gao, P.; Topp, E.M.; Patel, M.V. Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets. Int. J. Pharm., 1996, 142, 53-60.
24. Ju, R. T. C.; Nixon, P. R.; Patel, M. V. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J. Pharm. Sci., 1995, 84, 1455-1463.
25. Giunchedi, P.; Gavini, E.; Moretti, M.D.L.; Pirisino, G.; Evaluation of Alginate Compressed Matrices as Prolonged Drug Delivery Systems. AAPS PharmSciTech., 2000, 1, article 19.
26. Saravanan, M.; Dhanraj, M. D.; Sridhar, S. K.; Ramachandran, S.; Sam, S. K.; Rao, S. G. Preparation, characterization and in vitro release kinetics of ibuprofen polystyrene microspheres. Indian J. Pharm. Sci., 2004, 66, 287-292
27. Pandey, V. P.; Manavalan, R.; Sundarrajan, T.; Ganesh, K. S. Formulation and release characteristics of sustained release diltiazem hydrochloride tablets. Indian J. Pharm. Sci., 2003, 65, 44-48.
28. Ishikawa, T.; Watanabe, Y.; Takayama, K.; Endo, H.; Matsumoto, M. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC. Int. J. Pharm., 2000, 202, 173-178 (Pubitemid 30466244)
29. Chowdary, K. P.; Ramesh, K. V. Studies on microencapsulation of diltiazem. J. Pharm. Sci., 1993, 55, 52-54